EMBRACING FUTURE HOLDINGS LIMITED
Country of registration | Singapore |
Registration number | 200913076M |
Local SIC | |
Incorporation date | 19 Jul 2009 |
Company age | 16 years 10 months |
Official entity type | Public Company Limited By Shares |
No. of officers | 123 |
Contact
122 EMERALD HILL ROAD, Singapore 229405
This is the legal entity page of EMBRACING FUTURE HOLDINGS LIMITED. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- View MoreBiolidics is a medical technology company focused on developing cell enrichment systems for cancer diagnosis, prognosis, treatment selection, and treatment monitoring. Our patented technology, the ClearCell® FX1 System, separates and enriches cancer cells from blood samples, providing a simple and minimally invasive alternative to tissue biopsies. With installations in multiple countries, our technology has numerous applications throughout the cancer journey, from screening and staging to personalized treatment and post-cancer monitoring.
Fiscal/Budgeting Period | October - December |
Auditor | PKF-CAP LLP |
Revenue | 1m - 5m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 53,988,893 |
Frequently Asked Questions (FAQ)
- What is the address of EMBRACING FUTURE HOLDINGS LIMITED?
- Where is EMBRACING FUTURE HOLDINGS LIMITED's headquarter?
- What is EMBRACING FUTURE HOLDINGS LIMITED's contact number?
- What EMBRACING FUTURE HOLDINGS LIMITED's spending power?
- Does EMBRACING FUTURE HOLDINGS LIMITED have a presence in the domain it operates in?

